Polymorphisms in CYP1A1 and breast carcinoma risk in a population‐based case–control study of Chinese women

Cytochrome P450 1A1 (CYP1A1) is involved in the 2‐hydroxylation of estrogen, the hormone that plays a critical role in the etiology of breast carcinoma.

[1]  X. Shu,et al.  Correlation of Blood Sex Steroid Hormones with Body Size, Body Fat Distribution, and Other Known Risk Factors for Breast Cancer in Post-Menopausal Chinese Women , 2004, Cancer Causes & Control.

[2]  A. Hirvonen,et al.  Molecular epidemiology of sporadic breast cancer. The role of polymorphic genes involved in oestrogen biosynthesis and metabolism. , 2003, Mutation research.

[3]  S. Cummings,et al.  Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. , 2003, Journal of the National Cancer Institute.

[4]  W. Figg,et al.  2‐Methoxyestradiol, a Promising Anticancer Agent , 2003, Pharmacotherapy.

[5]  C. V. de Moura Gallo,et al.  CYP1A1, GSTM1, and GSTT1 polymorphisms and breast cancer risk in Brazilian women. , 2002, Cancer letters.

[6]  Y. Miyoshi,et al.  Breast Cancer Risk Associated with CYP1A1 Genetic Polymorphisms in Japanese Women , 2002, The breast journal.

[7]  B. Ponder,et al.  Polymorphisms in CYP1A1 and smoking: no association with breast cancer risk. , 2001, Carcinogenesis.

[8]  J. Potter,et al.  Association of body size and fat distribution with risk of breast cancer among Chinese women , 2001, International journal of cancer.

[9]  R. Brueggemeier,et al.  2-Methoxymethylestradiol: a new 2-methoxy estrogen analog that exhibits antiproliferative activity and alters tubulin dynamics , 2001, The Journal of Steroid Biochemistry and Molecular Biology.

[10]  A. LaCroix,et al.  Genetic susceptibility to breast cancer in French‐Canadians: Role of carcinogen‐metabolizing enzymes and gene–environment interactions , 2001, International journal of cancer.

[11]  I. Roots,et al.  Differential metabolism of benzo[a]pyrene and benzo[a]pyrene-7,8-dihydrodiol by human CYP1A1 variants. , 2001, Carcinogenesis.

[12]  J. Liehr,et al.  Estrogens as endogenous genotoxic agents--DNA adducts and mutations. , 2000, Journal of the National Cancer Institute. Monographs.

[13]  C. Ambrosone,et al.  Molecular epidemiology of genetic polymorphisms in estrogen metabolizing enzymes in human breast cancer. , 2000, Journal of the National Cancer Institute. Monographs.

[14]  Chen-Yang Shen,et al.  Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility. , 1999, Cancer research.

[15]  Chen-Yang Shen,et al.  Cytochrome P4501A1 polymorphism as a susceptibility factor for breast cancer in postmenopausal Chinese women in Taiwan. , 1999 .

[16]  S. Garte.  The role of ethnicity in cancer susceptibility gene polymorphisms: the example of CYP1A1. , 1998, Carcinogenesis.

[17]  W. Willett,et al.  Cigarette smoking, cytochrome P450 1A1 polymorphisms, and breast cancer risk in the Nurses' Health Study. , 1998, Cancer research.

[18]  M. Ingelman-Sundberg,et al.  In vitro kinetics of two human CYP1A1 variant enzymes suggested to be associated with interindividual differences in cancer susceptibility. , 1997, Biochemical and biophysical research communications.

[19]  J. Brockmöller,et al.  A C4887A polymorphism in exon 7 of human CYP1A1: population frequency, mutation linkages, and impact on lung cancer susceptibility. , 1996, Cancer research.

[20]  F. Guengerich,et al.  Characterization of purified human recombinant cytochrome P4501A1-Ile462 and -Val462: assessment of a role for the rare allele in carcinogenesis. , 1996, Cancer research.

[21]  W. B. Gleason,et al.  Oxidative transformation of 2-hydroxyestrone. Stability and reactivity of 2,3-estrone quinone and its relationship to estrogen carcinogenicity. , 1996, Chemical research in toxicology.

[22]  J. Liehr,et al.  4-Hydroxylation of estrogens as marker of human mammary tumors. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[23]  E. Taioli,et al.  A CYP1A1 restriction fragment length polymorphism is associated with breast cancer in African-American women. , 1995, Cancer research.

[24]  J. Freudenheim,et al.  Cytochrome P4501A1 and glutathione S-transferase (M1) genetic polymorphisms and postmenopausal breast cancer risk. , 1995, Cancer research.

[25]  E. Taioli,et al.  Functional significance of different human CYP1A1 genotypes. , 1994, Carcinogenesis.

[26]  K. Buetow,et al.  Genetics of CYP1A1: coamplification of specific alleles by polymerase chain reaction and association with breast cancer. , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[27]  E. Taioli,et al.  Role of estradiol metabolism and CYP1A1 polymorphisms in breast cancer risk. , 1999, Cancer detection and prevention.

[28]  J. Whitlock,et al.  Induction of cytochrome P4501A1. , 1999, Annual review of pharmacology and toxicology.

[29]  J. Freudenheim,et al.  Polychlorinated biphenyls, cytochrome P4501A1 polymorphism, and postmenopausal breast cancer risk. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[30]  N. Roodi,et al.  Breast cancer and CYPIA1, GSTM1, and GSTT1 polymorphisms: evidence of a lack of association in Caucasians and African Americans. , 1998, Cancer research.